电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2 (KCNH2) Peptide

KCNH2 宿主: 合成 BP, WB, IHC
产品编号 ABIN7236566
发货至: 中国
  • 抗原 See all KCNH2 products
    KCNH2 (Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2 (KCNH2))
    资源
    • 5
    合成
    应用范围
    Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
    原理
    KCNH2/HERG (extracellular) Negative Control Antigen
    序列
    AFLLKETEEG PPATEC correspond ing to residues 430-445 of human KV11.1 (HERG) (Accession Q12809).
    产品特性
    Synthetic peptide, A Blocking peptide for Anti-KCNH2 (HERG) (extracellular) Antibody (ABIN7043545, ABIN7045006 and ABIN7045007)). Intended to be used as a negative control.
    纯度
    >70 %
  • 应用备注
    Antigen Preadsorption Control: 2 μg peptide per 1 μg antibody.
    说明

    Confirmed by amino acid analysis and mass spectrometry.

    限制
    仅限研究用
  • 状态
    Lyophilized
    溶解方式
    100 μL double distilled water (DDW).
    浓度
    0.4 mg/mL
    储存条件
    RT,-20 °C
    储存方法
    Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
  • 抗原
    KCNH2 (Potassium Voltage-Gated Channel, Subfamily H (Eag-Related), Member 2 (KCNH2))
    别名
    ERG1 Peptide, HERG Peptide, HERG1 Peptide, Kv11.1 Peptide, LQT2 Peptide, SQT1 Peptide, erg Peptide, KCNH2 Peptide, ERG Peptide, gp-erg Peptide, cerg Peptide, derg Peptide, erg1 Peptide, AI326795 Peptide, LQT Peptide, Lqt2 Peptide, M-erg Peptide, Merg1 Peptide, merg1a Peptide, merg1b Peptide, potassium voltage-gated channel subfamily H member 2 Peptide, potassium voltage-gated channel, subfamily H (eag-related), member 6a Peptide, potassium voltage-gated channel, subfamily H (eag-related), member 2 Peptide, potassium voltage-gated channel subfamily H member 6 Peptide, KCNH2 Peptide, kcnh6a Peptide, Kcnh2 Peptide, KCNH6 Peptide
    基因ID
    3757
    NCBI登录号
    NM_000238
    UniProt
    O08962
You are here: